In silico and functional studies of the regulation of the glucocerebrosidase gene

Molecular Genetics and Metabolism

Volumn 99, Issue 3, 2010, Pages 275-282

  Blech Hermoni, Yotam N ^a   Ziegler, Shira G ^a   Hruska, Kathleen S ^a   Stubblefield, Barbara K ^a   LaMarca, Mary E ^a   Portnoy, Matthew E ^a   Green, Eric D ^a   Sidransky, Ellen ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Gaucher disease; Glucocerebrosidase; Luciferase assays; Multi species sequence comparisons; Transcriptional regulation

Indexed keywords

GLUCOSYLCERAMIDASE; LUCIFERASE; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; COMPUTER MODEL; CONTROLLED STUDY; GAUCHER DISEASE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE TARGETING; GENETIC VARIABILITY; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CATTLE; CERCOPITHECUS AETHIOPS; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; COS CELLS; DOGS; GAUCHER DISEASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSYLCERAMIDASE; HUMANS; LUCIFERASES, FIREFLY; MICE; MUTAGENESIS, SITE-DIRECTED; PHENOTYPE; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; VERTEBRATES;

MAMMALIA;

EID: 76349094268     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.10.189     Document Type: Article

References (22)

1. Beutler E., and Grabowski G. Gaucher disease. In: Beaudet A., Scriver C., Sly W., and Valle D. (Eds). The Metabolic & Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 3635-3668
2. Sidransky E. Gaucher disease: complexity in a "simple" disorder. Molecular Genetics and Metabolism 83 (2004) 6-15
3. Goker-Alpan O., Schiffmann R., Park J.K., et al. Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3. The Journal of Pediatrics 143 (2003) 273-276
4. Hruska K.S., LaMarca M.E., Scott C.R., et al. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Human Mutation 29 (2008) 567-583
5. Winfield S.L., Tayebi N., Martin B.M., et al. Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease. Genome Research 7 (1997) 1020-1026
6. Horowitz M., Wilder S., Horowitz Z., et al. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics 4 (1989) 87-96
7. Tayebi N., Stubblefield B.K., Park J.K., et al. Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease. American Journal of Human Genetics 72 (2003) 519-534
8. Frazer K.A., Ballinger D.G., Cox D.R., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (2007) 851-861
9. Koprivica V., Stone D.L., Park J.K., et al. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. American Journal of Human Genetics 66 (2000) 1777-1786
10. Dipple K.M., and McCabe E.R. Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. American Journal of Human Genetics 66 (2000) 1729-1735
11. Thomas J.W., Touchman J.W., Blakesley R.W., et al. Comparative analyses of multi-species sequences from targeted genomic regions. Nature 424 (2003) 788-793
12. Doll R.F., and Smith F.I. Regulation of expression of the gene encoding human acid beta-glucosidase in different cell types. Gene 127 (1993) 255-260
13. Doll R.F., Bruce A., and Smith F.I. Regulation of the human acid beta-glucosidase promoter in multiple cell types. Biochimica et Biophysica Acta 1261 (1995) 57-67
14. Moran D., Galperin E., and Horowitz M. Identification of factors regulating the expression of the human glucocerebrosidase gene. Gene 194 (1997) 201-213
15. Lee J., Lee H.J., Shin M.K., et al. Versatile PCR-mediated insertion or deletion mutagenesis. BioTechniques 36 (2004) 398-400
16. Jacobs J.L., and Dinman J.D. Systematic analysis of bicistronic reporter assay data. Nucleic Acids Research 32 (2004) e160
17. Margulies E.H., Blanchette M., Haussler D., et al. Identification and characterization of multi-species conserved sequences. Genome Research 13 (2003) 2507-2518
18. Collins M., Rojnuckarin P., Zhu Y.H., et al. A far upstream, cell type-specific enhancer of the mouse thrombospondin 3 gene is located within intron 6 of the adjacent metaxin gene. The Journal of Biological Chemistry 273 (1998) 21816-21824
19. Waterston R.H., Lindblad-Toh K., Birney E., et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420 (2002) 520-562
20. Christomanou H., Chabas A., Pampols T., et al. Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder. Klin Wochenschr 67 (1989) 999-1003
21. Pampols T., Pineda M., Giros M.L., et al. Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant. Acta Neuropathologica 97 (1999) 91-97
22. Diaz-Font A., Cormand B., Santamaria R., et al. A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity. Human Genetics 117 (2005) 275-277